COMMUNIQUÉS West-GlobeNewswire

Translate Bio Announces Third Quarter 2018 Financial Results and Reviews Recent Highlights
08/11/2018
Continued progress with ongoing Phase 1/2 clinical trial in CF and towards IND submission for OTC Deficiency LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger [...]
Chembio Diagnostics Reports Third Quarter 2018 Financial Results
08/11/2018
MEDFORD, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the third [...]
Globus Medical Reports Third Quarter 2018 Results
08/11/2018
AUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018. [...]
AnaptysBio Announces Third Quarter 2018 Financial Results and Provides Pipeline Updates
08/11/2018
Reported positive top-line data from an interim analysis of its ongoing Phase 2a proof-of-concept clinical trial of etokimab in severe eosinophilic asthma Initiated Phase 2 ECLIPSE trial of etokimab in chronic [...]
Terra Tech Corp Reports Financial Results for the Third Quarter of 2018
08/11/2018
IRVINE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its Third Quarter financial [...]
Dentsply Sirona Reports Third Quarter 2018 Results; Announces Restructuring Plan to Drive Value-Creation
08/11/2018
Reported Q3 revenues of $928.4 million, down 8.0% compared to prior year; constant currency decline 1 of 5.9% Q3 2018 GAAP EPS of $0.13 vs. $0.39 in Q3 2017. Q3 2018 Non-GAAP EPS of $0.38 compared with Non-GAAP EPS of $ [...]
Spero Therapeutics Announces Third Quarter 2018 Financial Results and Pipeline Overview
08/11/2018
Pipeline rapidly advancing with three clinical trials planned to initiate by early 2019, including a SPR994 Phase 3 initiation around year-end 2018 CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics [...]
Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
08/11/2018
MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today reported [...]
Nephros Reports Third Quarter 2018 Financial Results
08/11/2018
Quarterly Product Revenue Up 96% Year-over-Year; Total Revenue Up 88% SOUTH ORANGE, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018
08/11/2018
Reports Net Revenues of $75.5 Million for the Three Months Ended September 30, 2018 RANCHO CUCAMONGA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company [...]
Assertio Therapeutics Announces Third-Quarter 2018 Financial Results
08/11/2018
-- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Raises Full-Year Earnings Guidance and Confirms Adjusted EBITDA Guidance -- -- Amends and Strengthens Commercial Agreement with Collegium [...]
Caladrius Biosciences Reports 2018 Third Quarter Financial Results
08/11/2018
Development programs remain on track accompanied by continued strong fiscal management Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences [...]
Codexis Reports Third Quarter 2018 Financial Results
08/11/2018
Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Nov [...]
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Second-Quarter 2019 Results
08/11/2018
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Second orphan designation anticipated in first half of calendar 2019 Submit first IND in calendar 2020 SAN DIEGO, Nov. 08, [...]
Alder BioPharmaceuticals® to Present at Two Upcoming November Investor Conferences
08/11/2018
BOTHELL, Wash., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
ICU Medical, Inc. Announces Third Quarter 2018 Results
08/11/2018
Company Modifies FY 2018 Guidance and Provides Initial FY 2019 Adjusted EBITDA Guidance SAN CLEMENTE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture [...]
The Joint Corp. Reports Third Quarter 2018 Financial Results
08/11/2018
- Increases Annual System-Wide Gross Sales 31%, Compared to Third Quarter 2017 - - Grows Revenue 23%, Compared to Third Quarter 2017 - - Sells 60 Franchise Licenses January through September 2018, up from 37 in 2017 [...]
Collegium Reports Third Quarter Financial Results
08/11/2018
Net Product Revenues were $70.2 million for the third quarter of 2018, a 487% increase versus third quarter of 2017 Thirteen exclusive ER oxycodone formulary wins announced for Xtampza ER effective January 1, 2019 Cash [...]
BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
08/11/2018
BELBUCA ® continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarter BELBUCA total prescriptions experienced its largest quarter over quarter increase since launch [...]

Pages